Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-10-03 Sale |
2022-10-03 8:27 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
10,640 | $148.5 | $1,580,040 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-12-09 Option Award |
2024-12-11 6:48 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Mehta Kishan Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-04-30 Option Award |
2024-05-02 7:34 pm |
N/A 2034-04-30 |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
16,592 | $0 | 16,592 (Direct) |
View |
2023-05-02 Option Award |
2023-05-04 5:52 pm |
N/A 2033-05-02 |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
52,906 | $0 | 52,906 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:39 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
7,500 | $2.58 | 182,040 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:39 pm |
N/A 2032-04-28 |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
28,121 | $0 | 182,040 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:39 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
10,000 | $1.86 | 182,040 (Direct) |
View |
2022-10-03 Tax Withholding |
2022-10-05 5:39 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
11,716 | $7 | 182,040 (Direct) |
View |
2022-10-03 Option Award |
2022-10-05 5:39 pm |
N/A 2032-10-04 |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
125,000 | $0 | 182,040 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:39 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
6,502 | $4.61 | 182,040 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:39 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
4,119 | $4.84 | 182,040 (Direct) |
View |
2022-10-03 Other |
2022-10-05 5:39 pm |
N/A 2032-04-28 |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
34,378 | $0 | 182,040 (Direct) |
View |
Ownership |
2022-09-30 4:32 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Mehta Kishan Director |
0 | $0 | 0 (Direct) |
View |
2022-08-19 Exercise |
2022-08-23 5:28 pm |
N/A N/A |
Akili Inc. | AKLI | SCS Sponsor I LLC Mehta Kishan Cowen Aaron ChaChaCha DNA I LLC Former Director and 10% Owner Director |
6,220,000 | $0 | 6,860,000 (Direct) |
View |
2022-08-19 Other |
2022-08-23 5:28 pm |
N/A N/A |
Akili Inc. | AKLI | SCS Sponsor I LLC Mehta Kishan Cowen Aaron ChaChaCha DNA I LLC Former Director and 10% Owner Director |
6,860,000 | $0 | 6,860,000 (Direct) |
View |
2022-07-11 Exercise |
2022-07-13 4:25 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | SCS Sponsor III LLC Mehta Kishan Cowen Aaron ChaChaCha DNA III LLC Former Director and 10% Owner Director |
6,220,000 | $0 | 6,860,000 (Direct) |
View |
2022-07-11 Other |
2022-07-13 4:25 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | SCS Sponsor III LLC Mehta Kishan Cowen Aaron ChaChaCha DNA III LLC Former Director and 10% Owner Director |
6,860,000 | $0 | 6,860,000 (Direct) |
View |
2022-04-28 Option Award |
2022-04-29 9:04 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
8,239 | $0 | 8,239 (Direct) |
View |
2022-01-10 Exercise |
2022-01-12 9:04 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
1,875 | $0 | 12,515 (Direct) |
View |
2021-07-02 Option Award |
2021-07-07 8:56 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. IV | DNAD | SCS Sponsor IV LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA IV LLC Director 10% Owner |
640,000 | $10 | 640,000 (Direct) |
View |
2021-07-02 Option Award |
2021-07-07 8:52 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. III | DNAC | SCS Sponsor III LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA III LLC Director 10% Owner |
640,000 | $10 | 640,000 (Direct) |
View |
2021-07-02 Option Award |
2021-07-07 8:47 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. II | DNAB | SCS Sponsor II LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA II LLC Director 10% Owner |
640,000 | $10 | 640,000 (Direct) |
View |
2021-07-02 Option Award |
2021-07-07 8:42 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. I | DNAA | SCS Sponsor I LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA I LLC Director 10% Owner |
640,000 | $10 | 640,000 (Direct) |
View |
Ownership |
2021-06-29 8:43 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. IV | DNAD | SCS Sponsor IV LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA IV LLC Director 10% Owner |
0 | $0 | 6,295,000 (Direct) |
View |
Ownership |
2021-06-29 8:41 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. III | DNAC | SCS Sponsor III LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA III LLC Director 10% Owner |
0 | $0 | 6,295,000 (Direct) |
View |
Ownership |
2021-06-29 8:40 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. II | DNAB | SCS Sponsor II LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA II LLC Director 10% Owner |
0 | $0 | 6,295,000 (Direct) |
View |
Ownership |
2021-06-29 8:38 pm |
N/A N/A |
Social Capital Suvretta Holdings Corp. I | DNAA | SCS Sponsor I LLC Palihapitiya Chamath Mehta Kishan Cowen Aaron ChaChaCha DNA I LLC Director 10% Owner |
0 | $0 | 6,295,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-17 9:51 pm |
N/A 2031-06-15 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
13,004 | $0 | 13,004 (Direct) |
View |
Ownership |
2021-06-17 9:50 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
0 | $0 | 47,515 (Direct) |
View |